Treatment of Tinea Capitis
Oral systemic antifungal therapy is mandatory for tinea capitis, and the choice of agent depends on the causative organism: terbinafine for Trichophyton species (2-4 weeks) and griseofulvin for Microsporum species (6-8 weeks). 1
Diagnostic Confirmation Before Treatment
- Collect scalp samples via scrapings, hair pluck, brush, or swab for microscopy and culture to identify the causative organism 1
- Potassium hydroxide (KOH) preparation provides rapid preliminary diagnosis 1, 2
- Start empirical treatment immediately if cardinal clinical signs are present (scale, lymphadenopathy, alopecia, or kerion) without waiting for culture results 1
First-Line Treatment Algorithm
For Trichophyton Species Infections
Terbinafine is the preferred agent due to fungicidal activity and superior efficacy with shorter treatment duration 1:
- Children <20 kg: 62.5 mg/day for 2-4 weeks 1
- Children 20-40 kg: 125 mg/day for 2-4 weeks 1
- Children >40 kg and adults: 250 mg/day for 2-4 weeks 1
- Gastrointestinal disturbances and rashes occur in <8% of children 1
- The shorter duration (2-4 weeks vs 6-8 weeks) significantly improves compliance 1
For Microsporum Species Infections
Griseofulvin is the only effective first-line agent for Microsporum infections 1:
- Children <50 kg: 15-20 mg/kg/day for 6-8 weeks 1, 2
- Children >50 kg and adults: 1 g/day for 6-8 weeks 1, 2
- Critical pitfall: Terbinafine fails against Microsporum because it cannot be incorporated into hair shafts in prepubertal children and doesn't reach the scalp surface where arthroconidia are located 1
- Eight weeks of griseofulvin is significantly more effective than 4 weeks of terbinafine for confirmed Microsporum infection 1
Second-Line Options for Treatment Failure
If initial therapy fails, consider these factors: poor compliance, suboptimal drug absorption, organism insensitivity, or reinfection 1
Management algorithm for treatment failure 1:
- If clinical improvement but positive mycology persists: Continue current therapy for additional 2-4 weeks
- If no clinical improvement: Switch to second-line therapy
Second-Line Agents
- Itraconazole: 5 mg/kg/day for 2-4 weeks or 50-100 mg/day for 4 weeks, effective against both Trichophyton and Microsporum species 1
- Fluconazole: Alternative for refractory cases with favorable tolerability profile and availability in liquid form 1
Adjunctive Measures
- Topical antifungal shampoos (selenium sulfide or ketoconazole) as adjunctive therapy to reduce spore transmission 1
- Screen and treat family members and close contacts, especially for T. tonsurans infections which spread easily 1
Monitoring and Treatment Endpoint
- Treatment endpoint is mycological cure, not just clinical improvement 1
- Repeat mycology sampling until clearance is achieved 1
- Monitor for treatment side effects, though liver enzyme monitoring is generally unnecessary if therapy is limited to ≤4 weeks 3
Critical Pitfalls to Avoid
- Never use terbinafine for Microsporum infections due to poor efficacy 1
- Never rely on topical therapy alone as it cannot eradicate scalp infections 1
- Avoid underdosing griseofulvin—higher doses (20-25 mg/kg/day) are needed due to increasing treatment failures with lower doses 1, 3
- Do not discontinue therapy prematurely—clinical relapse will occur if medication is not continued until the infecting organism is completely eradicated 2